Alzheimer’s Accountability and Investment Act

The Alzheimer’s Accountability and Investment Act (HR 620) requires the National Institutes of Health (NIH) Director to annually submit a budget estimate for Alzheimer’s-related initiatives - including personnel needs - directly to the President for review and then to Congress. This budget must be prepared after public comment and submitted without changes by the Secretary of Health and Human Services or the Advisory Council. The bill directly affects the NIH’s budget reporting process for Alzheimer’s research and programs, mandating transparency in how funds are allocated. It does not change funding levels but establishes a specific annual reporting mechanism to improve accountability.